Cerebrohepatorenal syndrome of Zellweger (Zellweger syndrome)

NeuroLearn NeuroHelp Metabolic @ Peroxisomal disorders, classification

Background    Gross Pathology    Histopathology & Immunohistochemistry

BACKGROUND AND CLINICAL INFORMATION: Head  

Summary: Cerebrohepatorenal syndrome of Zellweger (Zellweger syndrome) is a peroxisomal disease that is  biochemically characterized by abnormal accumulation of very long chain fatty acid, and morphologically characterized by a neuronal migration defect, typically pachymicrogyria, affecting both the cerebral hemisphere and cerebellar hemisphere. This is the first syndrome known in which malformations of the brain and other organs are associated with an inborn error of metabolism.

Spectrum: Zellweger syndrome, neonatal adrenoleukodystrophy (NALD), and Infantile Refsum’s disease constitute a disease continuum of peroxisomal disorders. Migration disorders, can be seen in both Zellweger syndrome and, less severely, in NALD. No malformation has been reported in infantile Refsum’s disease.

Background: Cerebrohepatorenal syndrome of Zellweger is the most severe form of peroxisomal disorder due to errors in peroxisomal biogenesis or defects in maintaining peroxisomal intergrity. This group constitues the generalized peroxisomal disorders and are inherited as autosomal recessive traits. There is loss of multiple peroxisomal enzyme activities often associated with morphological abnormalities of peroxisomes. Many of the disorders in this group are due to defects in importing protein(s) into the peroxisomes.

Biochemistry: The peroxisomal Beta-oxidation is impaired and lead to the accumulation of saturated very long chain (over 22 carbon) fatty acid (VLCFA). Measurment of VLCFA level is the mainstay of biochemical diagnosis. Other clinically useful markers include dihydroxyacetone phosphate acyl transferase (DHAP-AT), red blood cell plasmalogens, phytanic acid and piperocolic acid level.

Genetics: Autosomal recessive. There are at least 10, probably more, different human genes involved in peroxisome assembly. Mutation of peroxisomal membrane protein-1 (PXMP1) on chromosome 1p22-21 and peroxisomal assembly factor-1 (PAF1) on chromosome 8q21.1 have been identified in patients with Zellweger syndrome.

Incidence: 1 in 100,000, and may be an underestimate.

Clinical features:

GROSS PATHOLOGY: Head  

Features of a migration disorder in CNS:

Dysplastic dentate and olivary nuclei are seen in the majority of patients.

Other abnormal CNS findings: These include a thin corpus callosum, decrease in the volume and amount of myelination of white matter in the cerebral hemispheres for age, increased size of the lateral and third ventricles, subependymal cysts over the caudate ncueli, small olfactory bulbs, small gliotic optic nerves, and occasionally a hypoplastic cerebral vermis.

Other organs:

HISTOPATHOLOGY AND IMMUNOHISTOCHEMISTRY: Head  

Adrenal gland: Abnormal trilamina and lamellar lipid bodies are found in some cases.

Aberrant astroglial tissue under the pia, varying from a small focal wedge-shaped area of the bottom of a shallow abnormal sulcus to sheets of glial tissue that covers a gyrus or several of the small abnormal gyri.

Cortical architecture:

Abnormal cell clusters:

Cerebellum: The cerebellar cortex also shows heterotopia of Purkinje cells.

Brain stem: The only abnormality is that the inferior olivary nuclei fail to become normally convoluted.

Electron microscopy: At EM level, various inclusion bodies have been described. Macrophages containing lipid droplets and lamellae are present.

NeuroLearn NeuroHelp Metabolic For Comment: KarMing-Fung@ouhsc.edu

Background    Gross Pathology    Histopathology & Immunohistochemistry